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Abstract 
 
Connexin (Cx) and pannexin (Panx) proteins form large conductance channels, which 
function as regulators of communication between neighboring cells via gap junctions 
and/or hemichannels. Intercellular communication is essential to coordinate cellular 
responses in tissues and organs, thereby fulfilling an essential role in the spreading of 
signaling, survival and death processes. The functional properties of gap junctions and 
hemichannels are modulated by different physiological and pathophysiological 
stimuli. At the molecular level, Cxs and Panxs function as multi-protein channel 
complexes regulating their channel localization and activity. In addition to this, gap 
junctional channels and hemichannels are modulated by different post-translational 
modifications, including phosphorylation, glycosylation, proteolysis, N-acetylation, S-
nitrosylation, ubiquitination, lipidation, hydroxylation, methylation and deamidation. 
These PTMs influence almost all aspects of communicating junctional channels in 
normal cell biology and pathophysiology. In this review, we will provide a systematic 
overview of PTMs of communicating junction proteins and discuss their effects on Cx 
and Panx-channel activity and localization. 
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1. General introduction communicating junction proteins 
 
Three families of proteins, described as connexin (Cx), pannexin (Panx) and innexin 
(Inx) proteins, are well known to form large conductance channels. Inxs, Cxs and 
Panxs belong to one superfamily (Baranova et al., 2004; Phelan et al., 1998). The 
invertebrate Inx family counts 25 genes in C. elegans and 8 Drosophila melanogaster 
genes (Phelan, et al., 1998; Yen and Saier, 2007). The vertebrate Cx family contains 21 
human Cx genes and the vertebrate Panx family of mammalian proteins contains 3 
members (Panx1, Panx2 and Panx3). Cxs, Panxs and Inxs are transmembrane proteins 
consisting of a cytoplasmic N-terminal domain (NT), 4 typical transmembrane 
domains (TM; TM1, TM2, TM3, TM4), 2 extracellular loop domains (EL1 and EL2), one 
cytoplasmic loop domain (CL) and a cytoplasmic C-terminal domain (CT) (Fig. 1). Cx 
and Panx families show structural and functional similarities, including the ability to 
form gap junction channels and hemichannels. Yet, the role of Panxs as functional gap 
junction channels on the physiological level remains debated (for review see D'hondt 
et al., 2009). Moreover, Sosinsky and coworkers claimed that since Panx oligomers 
are, until now, shown to only form functional channels in unapposed membranes, and 
they should be referred to as channels and not hemichannels (Sosinsky et al., 2011). 
Very recently, a new protein family, Ca2+-homeostasis modulator 1 (CALHM1), has been 
shown to structurally and functionally resemble Cx- and Panx channels (Siebert et al., 
2013) and to mediate purinergic signaling from taste buds to the gustatory nerves in 
response to sweet, bitter and umami taste molecules (Taruno et al., 2013).  
In the plasma membrane, these channels function as regulators of communication 
between neighboring cells, either in a direct way by the formation of gap junction 
channels, which are formed when two hemichannels of adjacent cells dock, or in an 
indirect paracrine manner by controlling exchange of ions and metabolites between 
the intra- and extracellular environment through unopposed hemichannels (reviewed 
in (D'hondt et al., 2009; D'hondt et al., 2010)). It is evident that gap junction channels 
and especially hemichannels need to be tightly regulated to assure cell survival. Not 
surprisingly, different physiological stimuli such as increased intracellular 
acidification (Morley et al., 1997), altered transmembrane or transjunctional potential 
(Palacios-Prado and Bukauskas, 2011), changes in intra- and extracellular calcium 
concentrations (De Vuyst et al., 2006; De Vuyst et al., 2009){Ponsaerts, 2010 
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#394;Ponsaerts, 2012 #826} and RhoA signaling {Derangeon, 2008 #1026;Seminario-
Vidal, 2011 #1025;Ponsaerts, 2012 #1027}, have been found to modify the 
functionality of gap junctions and hemichannels. In addition, numerous proteins have 
been found to interact with these channels and some have been shown to affect 
channel localization and activity (Herve et al., 2012). Channel-binding proteins can be 
modified by proteins with enzymatic activity inducing the so-called post-translational 
modifications (PTMs) (Johnstone et al., 2012).  
In this review, we provide an overview of important and recent PTMs of 
communicating junction proteins that affect assembly, trafficking and function of Cx- 
and Panx-based channels. We will mainly focus on phosphorylation, glycosylation and 
proteolysis. We organized the description of the PTMs from PTMs for which more is 
known regarding sites of modification and functional consequences to PTMs for which 
much less or very little is known. 
 
2. General introduction PTMs 
 
The term PTM indicates changes in the polypeptide chain as a result of either the 
addition or removal of covalent functional groups or proteins. These modifications 
include phosphorylation, glycosylation, proteolysis, lipidation, N-acetylation, S-
nitrosylation, ubiquitination, lipidation, hydroxylation, methylation and deamidation.. 
These PTMs can be reversible (e.g., phosphorylation) or irreversible (e.g., proteolysis, 
ubiquitination, sumoylation).  
 
Protein PTMs play a key role in many cellular processes such as cellular 
differentiation (Grotenbreg and Ploegh, 2007), protein degradation (Geiss-
Friedlander and Melchior, 2007), signaling and regulatory processes (Morrison et al., 
2002), regulation of gene expression (Vinken et al., 2006), and protein-protein 
interactions (Larsen et al., 2006). Therefore, identifying and understanding PTMs is 
critical in the study of cell biology and disease treatment and prevention. Currently, 
more than 60 types of PTMs are described in dbPTM 
(http://dbptm.mbc.nctu.edu.tw/), a freely accessible database that contains validated 
and predicted information on protein PTMs (Lee et al., 2006).  
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Traditionally, PTMs have been identified by Edman degradation, thin-layer 
chromatography, amino acid analysis, isotopic labeling (e.g., [32P]- phosphate 
incorporation), immunochemistry by applying pan-specific anti-PTM antibodies (e.g., 
pan- phosphotyrosine) or PTM-site-specific antibodies (e.g., anti-phosphoserine 
residue 368 of Cx43) and nuclear magnetic resonance (e.g., 31P-NMR) (Kee and Muir, 
2012; Larsen, et al., 2006). The technique that is now widely used in proteomics to 
identify PTMs is mass spectrometry (MS) (Aebersold and Mann, 2003; Yates et al., 
2005). MS is a robust quantitative technique to identify PTMs by their mass-value and 
to map the PTM-sites within a protein (Larsen, et al., 2006). In this technique, the 
mass increment or deficit as a result of PTM-induced changes in molecular weight of 
the modified amino acids, is measured (Larsen, et al., 2006).  
 
Various PTMs have been reported to alter the regulation and localization of Cxs 
(Johnstone, et al., 2012). Glycosylation is the PTM that has been studied most 
extensively for Panxs. To the best of our knowledge, no reports have yet been 
published about PTMs of Inxs. An overview of PTMs either determined of predicted 
are presented in figure 1 (for Cxs) and figure 2 (for Panxs). 
 
 
3. Communicating junction proteins and PTMs 
 
3.1 Phosphorylation 
 
Protein phosphorylation is a reversible process in which protein functions are 
regulated by kinase-mediated addition of a phosphate group, principally to serine (S), 
threonine (T) or tyrosine residues (Y) (Ciesla et al., 2011; Davis, 2011). Many critical 
events involved in cellular response are mediated by phosphorylation and 
dephosphorylation, such as regulation of enzymatic activity, protein conformational 
change, protein-protein interaction, and cellular localization (Davis, 2011; Huttlin et 
al., 2010; Nishi et al., 2011). Abnormal phosphorylation has been implicated in many 
severe diseases (Colomer and Means, 2007; Saez et al., 2003).  
 
Cx26, Cx31, Cx32, Cx36, Cx37, Cx40, Cx43, Cx45, Cx46, Cx50 and Cx56 have been 
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shown to be phophoproteins (Lampe and Lau, 2000; Lampe et al., 2000; Locke et al., 
2009; Saez et al., 1998) (Fig. 1, Table 1). As for many other phosphorylation research 
fields, Cx-phosphorylation research focused on serine (S), threonine (T) and tyrosine 
(Y) amino acids via protein kinase B (PKB/Akt) (Dunn et al., 2011), c- and v-src, 
mitogen-activated protein kinase (MAPK), protein kinase C (PKC), p34cdc2, casein 
kinase 1 (CK1), protein kinase A (PKA) or calmodulin-dependent protein kinase 
pathways (Lampe and Lau, 2004; Lampe, et al., 2000; Saez, et al., 1998; Solan and 
Lampe, 2005, 2009) (Table 1). For Cxs, no phosphorylation events of basic amino 
acids are described. 
In Cxs, phosphorylation of cytoplasmic residues mainly occurs in the C-terminal 
domain (Cooper et al., 2000; Rikova et al., 2007; Wisniewski et al., 2010), and 
occasionally in the N-terminal domain (Chen et al., 2012; Wisniewski, et al., 2010) or 
cytoplasmic loop domain (Alev et al., 2008; Berthoud et al., 1997; Rigbolt et al., 2011) 
(Fig. 1, Table 1). In multiple tissues, Cxs are regulated by multi-site phosphorylation 
resulting in altered Cx-protein synthesis and turnover, trafficking, membrane 
insertion and aggregation. Hence, Cx phosphorylation is involved in the efficient 
delivery of hemichannels to the gap junction plaque (Johnson et al., 2012; Palatinus et 
al., 2011a), gap junction channel assembly, function, and turnover under both normal 
and disease conditions (Laird, 2005; Lampe and Lau, 2000, 2004; Marquez-Rosado et 
al., 2011; Saez, et al., 2003; Saez, et al., 1998; Solan and Lampe, 2005, 2007, 2009). 
However, it is suggested that phosphorylation is neither required for Cx insertion to 
the membrane (Musil et al., 1990; Solan and Lampe, 2005) nor for the formation of 
functional channels (Johnstone et al., 2009; Martinez et al., 2003). Moreover, Cx43 
truncated at aa 236 was compromised in trafficking to the membrane, while Cx43 
truncated at aa 239 remained able to traffic to the membrane and form functional gap 
junction channels, but not functional hemichannels (De Vuyst et al., 2007; Wayakanon 
et al., 2012). Thus, only a portion of the Cx43 C-terminal domain is shown to be 
required for its trafficking. 
Recently, the effects of phosphorylation on Cx43 structure and function have been 
extensively reviewed (Jeyaraman et al., 2011; Johnstone, et al., 2012; Marquez-
Rosado, et al., 2011; Solan and Lampe, 2009). A list of Cx43 phosphopeptide 
sequences and an extensive overview of Cx43 multi-site phosphorylation (primarily at 
S) is provided by Chen and coworkers (Chen, et al., 2012). Much less is known for the 
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other Cx subtypes. We will first give an overview of Cx43 phosphorylation and then 
provide the current state of-the-art of the other Cx subtypes and Panxs. Here, we will 
focus on the phosphorylation of Cx43 and the current knowledge about the 
phosphorylation-dependent regulation of other Cx and Panx isoforms.  
 
3.1.1 Phosphorylation of Cx43 
 
The C-terminal domain of Cx43 plays an important role in the efficient assembly of 
gap junction channels, which organize into symmetrical arrays resulting in the 
formation of gap junction plaques (Bruzzone et al., 1996; White et al., 1995). These 
gap junction plaques are located in the vicinity of adherens and tight junctions 
forming the junctional complex, which is linked to the actin cytoskeleton via linker 
molecules such as zonula occludens-1 and -2 (ZO-1 and ZO-2) (reviewed in 
(Giepmans, 2004)). ZO-1 and ZO-2 interact with Cx43 (Singh et al., 2005) and control 
Cx43 trafficking to gap junction plaques (Hunter et al., 2005; Jin et al., 2004; Segretain 
et al., 2004; Toyofuku et al., 1998). The C-terminal domain of Cx43 contains 32 amino 
acid residues that are phosphorylated by protein kinases (Chen, et al., 2012; Marquez-
Rosado, et al., 2011), 15 residues are S residues that are phosphorylated by 
Ca2+/calmodulin protein kinase II (CaMKII) (Huang et al., 2011), a protein kinase 
regulating Ca2+ homeostasis, transcription, apoptosis, and ischemic heart disease 
(Colomer and Means, 2007; Gomez et al., 2009; Singh et al., 2012).  
Cx43 is phosphorylated on Y265 and Y247 by v-src (Lin et al., 2001; Solan and Lampe, 
2008; Swenson et al., 1990). The interaction of src with Cx43 upon phosphorylation at 
Y265 is shown to regulate the interaction between Cx43 and ZO-1, but whether src 
phosphorylation of Cx43 on Y265 and/or Y247 directly inhibits gap junctional 
communication or whether MAP kinase phosphorylation of Cx43 plays a more direct 
role is still debated (Cottrell et al., 2003; Lin, et al., 2001; Zhou et al., 1999). CK1-
mediated phosphorylation of C-terminal domain of Cx43 at S364 (TenBroek et al., 
2001), S325 (Cooper and Lampe, 2002), S328 (Cooper and Lampe, 2002) and S330 
(Cooper and Lampe, 2002) increased gap junction assembly and coupling and 
enhanced gap junctional communication (Lampe et al., 2006). Consistent with this, 
CK1 inhibition significantly reduced Lucifer Yellow dye transfer, hinting that CK1-
mediated Cx43 phosphorylation of S325/S328/S330 contributes to establish 
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functional gap junctional channels. These data are fully in line with the recent in vivo 
findings using knock in-mouse models, in which Cx43-S325A/S328A/S330A hampers 
gap junction channel functions, while Cx43-S325E/S328E/S330E improves gap 
junction channel functions (Remo et al., 2011). These mice were highly susceptible to 
inducible arrhythmias, while the phospho-mimick (Cx43-S325E/S328E/S330E) knock 
in mice showed a reduced susceptibility to inducible arrhythmias and were resistent 
to acute and chronic pathological gap junction-remodeling (Remo, et al., 2011).  
 
Phosphorylation of the C-terminal domain Cx43 at Y265 (Toyofuku et al., 2001) and at 
S372/S373 prevents the interaction with the PDZ2-domain of ZO-1, acting as an 
on/off switch for interaction of Cx43 with ZO-1 (Chen et al., 2008; Xiao et al., 2011), 
and thus regulating the formation of gap junction channels (Rhett and Gourdie, 2012). 
The ZO-1–Cx43 interaction, which is concentrated in a region of the plasma 
membrane surrounding the gap junction plaque called the perinexus, governs a 
balance between undocked connexons in the perinexus and connexons docked in 
functional intercellular channels in the gap junction (Hunter, et al., 2005; Rhett and 
Gourdie, 2012). Kalcheva and coworkers (Kalcheva et al., 2007) also showed that the 
I130T mutation interferes with Cx43 phosphorylation. As a consequence, this 
mutation results in diminished trafficking and assembly of junctional channels, 
reduced cell-cell coupling, slowing of impulse propagation, and enhanced arrhythmic 
potential. 
Several other studies have linked reduced gap junctional communication to Cx43 
phosphorylation at different sites, namely at Y247 (Solan and Lampe, 2008), at S255 
(Cottrell, et al., 2003; Kanemitsu et al., 1998; Lampe et al., 1998; Warn-Cramer et al., 
1998), at S262 (Doble et al., 2004; Norris et al., 2008; Solan and Lampe, 2008; 
Srisakuldee et al., 2009), at Y265 (Solan and Lampe, 2008), at S279 (Cottrell, et al., 
2003; Warn-Cramer, et al., 1998), at S282 (Cottrell, et al., 2003; Solan and Lampe, 
2008; Warn-Cramer, et al., 1998) and at S368 (Ek-Vitorin et al., 2006; Palatinus et al., 
2011b; Richards et al., 2004; Solan and Lampe, 2008; Srisakuldee, et al., 2009; Straub 
et al., 2009). Direct phosphorylation of Cx43 at S368 also reduced hemichannel 
opening (Bao et al., 2004). Cx43 phosphorylation at S262 and at S368 occurred during 
global ischaemia and was accompanied by attenuation of ischaemia-induced Cx43 
dephosphorylation and prevention of Cx43 lateralization (Srisakuldee, et al., 2009). 
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PKCepsilon-dependent Cx43 phosphorylation at S262 is associated with 
cardioprotection (Srisakuldee, et al., 2009) (Miura et al., 2007). PKC-dependent Cx43 
phosphorylation at S368 results in increased Cx43 gap junction-channel permeability, 
reduced unitary conductance (Ek-Vitorin, et al., 2006), and restored gap junctional 
communication regulating wound healing (Richards, et al., 2004). Scratch wounding 
of primary human keratinocytes caused an increase in Cx43 phosphorylation at S368 
in cells adjacent to the scratch, and a reduced dye transfer at the edge of the scratch. 
In vivo, phosphorylation of Cx43 at S368 was increased in the injury border zone 
acutely following ventricular injury, which may contribute to reductions in inducible-
arrhythmia following injury (O'Quinn et al., 2011). 
Cx43 internalization from the gap junction plaque as well as Cx turnover (Laird, 2005; 
Lampe and Lau, 2000) is associated with phosphorylation at S255 and S262 during 
mitosis (Kanemitsu, et al., 1998; Lampe, et al., 1998), at S365 (Beardslee et al., 2000; 
Solan and Lampe, 2007) and at S368 (Lampe and Lau, 2000). 
Direct phosphorylation of Cx43, resulting from PKB/Akt activation, controls gap 
junction stability and is necessary to form larger stable gap junctions (Dunn, et al., 
2011). This phosphorylation of Cx43 may provide important novel insights in the 
downstream targets of the pro-survival and growth function of Akt signaling in cells. It 
is important to note that Akt not only phosphorylates Cx43 channels but also IP3R 
channels to prevent pro-apoptotic Ca2+ signaling (Marchi et al., 2012; Szado et al., 
2008){Decuypere, 2011 #1028;Vanderheyden, 2009 #1029}. Thus, it is not excluded 
that Akt may negatively regulate Cx hemichannels or Panx channels, given their role in 
cell death (Chekeni et al., 2010; Sandilos et al., 2012){Decrock, 2009 #1035;Decrock, 
2012 #960;Decrock, 2009 #1034}. 
 
Also non-channel functions in cell growth are described for Cxs. For instance, a Cx-
specific cis-acting gene module, pointed as a Cx-response element in the promoter 
region, is suggested to modulate the expression of tissue homeostasis gatekeepers. 
Moreover, the interaction of Cxs with regulators of cell growth and cell death possibly 
occurs via the interplay of Cxs with a number of key tissue homeostasis determinants 
like β-catenin, E-cadherin, ZO proteins, ZO-1-associated nucleic acid binding protein, 
etc., (reviewed in (Vinken et al., 2011)). The expression of multiple apoptotic genes is 
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altered upon knock-down of Cx43 (Iacobas et al., 2003), and the production or the 
activity of a plethora of tissue homeostasis regulators can be affected by Cx proteins, 
as single entities (Zhang et al., 2003), hereby possibly affecting the establishment of 
gap junctional intercellular communication. Cxs, or at least specific parts of Cxs, reside 
in the cell nucleus, where they might directly affect gene transcription, but the exact 
mechanisms of these channel-independent actions of Cxs remain largely unknown. 
Upon forced Cx43 expression, the C-terminal tail portion shows a diffuse distribution 
in the cell, including the nucleus, resulting in the inhibition of cell growth (reviewed in 
(Vinken, et al., 2011)). Cx43 overexpression inhibits DNA synthesis independent of 
cell-cell contacts or coupling in neonatal cardiomyocytes (Doble, et al., 2004). PKC-
mediated phosphorylation of different Cx43 residues, including S262 (Doble et al., 
1996; Doble, et al., 2004; Doble et al., 2000), overrules the Cx43-dependent effect on 
growth inhibition (Dang et al., 2003) in embryonic and neonatal cardiomyotes. 
Importantly, Cx43-S262D, a phospho-mimicking Cx43 variant, was severely 
compromised in inhibiting DNA synthesis. In contrast, Cx43-S262A, a phospho-dead 
Cx43 variant, was very potent in inhibiting DNA synthesis. Importantly, in the absence 
of cell-to-cell contacts, Cx43’s inhibitory effect on DNA synthesis was not affected by 
the S262A or S262D mutations, indicating that phosphorylation only regulates Cx43-
mediated inhibition of DNA synthesis in the presence of cell-to-cell contacts (Doble, et 
al., 2004). Yet, the ability of phosphorylation of Cx43 to abolish the inhibition of cell 
growth by Cx43 does not require Cx43’s ability to form gap junction channel forming 
ability (Doble, et al., 2004). Thus, it is anticipated that Cx43 phosphorylation on S262 
and other sites is a likely mechanism by which mitogens promote DNA synthesis and 
cardiomyocyte proliferation and growth despite their cell-cell contacts. Besides 
reducing growth by itself, the C-terminal domain of Cx43 has been demonstrated to 
enhance cell motility (increase glioma migration) and is sufficient to induce actin 
cytoskeleton reorganization (Bates et al., 2007; Crespin et al., 2010). 
 
 
3.1.2 Phosphorylation of other Cx isoforms 
 
For a long time, Cx26, with its very short C-terminal domain, was assumed not to be 
regulated by phosphorylation (Traub et al., 1989). Detailed studies from Locke and 
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coworkers identified Cx26 phosphorylation at T123 in the cytoplasmic loop domain, 
at T177 in EL2, at S183 and T186 near the border of EL2 and TM4 (Locke, et al., 2009) 
(Fig. 1, Table 1). The effects of phosphorylation in the cytoplasmic loop domain, a 
domain in which at least two other Cxs (Cx36 and Cx56) are phosphorylated 
(Berthoud, et al., 1997; Urschel et al., 2006), remain poorly characterized. T123N is a 
possible Cx26deaf missense mutation, but there is no information on the functional 
effects of mutation at this site (Locke, et al., 2009; Park et al., 2000). According to the 
Cx26 crystal structure (Maeda et al., 2009), T177 forms a docking interaction with the 
apposed hemichannel. S183 might play a role in regulating hemichannel docking, 
since Cx26deaf S183F mutation significantly reduces the formation of junctional 
channels (de Zwart-Storm et al., 2008). 
 
Cx31 phosphorylation at S263 and S266 regulates Cx31 turnover and increases 
intercellular communication, but Cx31 phosphorylation did not affect the intracellular 
trafficking of gap junction proteins (Diestel et al., 2004). Phosphorylation of S263 is 
crucial to allow the action of CK1 at S266. A rapid decrease of phosphorylation is 
shown upon exchange of one (S266) or both serine residues (263 and 266), pointing 
out the predominant role of phosphorylation at position 263 (Diestel, et al., 2004). 
 
Phosphorylation of Cx32 at S233 (Saez et al., 1990) via either cAMP-dPK or PKC (Saez, 
et al., 1990; Saez, et al., 1986; Takeda et al., 1989; Traub et al., 1987), is temporally 
correlated with an increased junctional conductance and an increased intercellular 
gap junctional communication (Chanson et al., 1996). Also, S229 is phosphorylated, 
but to a lesser extent than S233 (Saez, et al., 1990). Cx32 is phosphorylated at T243 by 
the epidermal growth factor receptor (Diez et al., 1995). In addition, alterations in the 
phosphorylation state of the C-terminal tail of Cx32 might regulate myelin 
homeostasis (Stauch et al., 2012). 
 
Cx36 and the fish orthologue Cx35 are targets for multiple kinases (Kothmann et al., 
2007; Kothmann et al., 2009; Patel et al., 2006; Urschel, et al., 2006). Phosphorylation 
of Cx36 was identified at S110, T111, S293 and S315, resulting in an increased 
synaptic efficacy in the form of “run-up” of junctional conductance in N2A cells 
expressing Cx36 (Alev, et al., 2008). PKA-mediated phosphorylation of Cx36 was 
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associated with a decreased gap junctional communication (Urschel, et al., 2006). In 
contrast, PKA activation of protein phosphatase 2A and subsequent 
dephosphorylation of Cx36 at S293 results in Cx36 gap junction uncoupling in retinal 
AII amacrine cells, thus Cx36 phosphorylation is required for AII amacrine cell 
coupling strength (Kothmann, et al., 2009). This regulation is likely controlled at the 
level of individual Cx36 plaques and phosphorylation of Ser293 appears to influence 
permeability of Cx36 gap junctions but not the trafficking of Cx36 (Kothmann, et al., 
2009). 
 
Cx37 phosphorylation at S319 mediated by glycogen synthase kinase-3, a kinase 
known to be implicated in cell proliferation and cancer, was shown to be associated 
with reduced gap junctional intercellular communication (Morel et al., 2010). 
 
PKA-mediated phosphorylation of Cx40 (probably at S120 or S345, which are the 
known predicted Cx40 PKA phosphorylation sites (Kemp and Pearson, 1990; Kennelly 
and Krebs, 1991)) regulates Cx40 gap junction function (van Rijen et al., 2000). In 
vivo, this may lead to an increase in intercellular conductivity and permeability in the 
vasculature and the heart where Cx40 is expressed (van Rijen, et al., 2000). 
 
Cx45 phosphorylation in the C-terminal domain to differentially regulates electrical 
intercellular conductance via Cx45 gap junctions. Yet, regulation did not alter the 
single channel conductance, but most likely modulates the open probability of Cx45 
gap junction channels (van Veen et al., 2000). Phosphorylation of Cx45 occurs at S381, 
S382, S384 and S385. Mutating these serine residues into phospho-dead mutants 
increased the turnover rate of Cx45 (Hertlein et al., 1998). 
 
Low levels of Cx46 synthesis and slow rate of Cx46 phosphorylation was shown in rat 
embryo lens primary cultures and in bovine organ cultures (Jiang et al., 1993). Cx46 
phosphorylation (mainly at T residues (Lin et al., 2004; Zampighi et al., 2005) and for 
a small fraction at S residues (Lin, et al., 2004)) in the C-terminal domain (also for the 
bovine orthologue Cx44) (Shearer et al., 2008)was suggested to occur via PKC-gamma 
activation (Lin, et al., 2004; Saleh et al., 2001). Interestingly, a role for PKC-gamma is 
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suggested in control of lens cortical gap junctions (Saleh, et al., 2001). 
 
Cx50 phosphorylation at T residues was shown in in the whole lens (Lin, et al., 2004), 
and at S residues in both the C-terminal domain and the central cytoplasmic loop 
domain in the bovine orthologue Cx49 (Shearer, et al., 2008). PKC-gamma-mediated 
phosphorylation at S and T residues decreased the density of Cx50 channels 
assembled in gap junctions, while increasing the density of Cx50 hemichannels 
(Zampighi, et al., 2005). In the chicken lens, Cx50 (chicken orthologue is Cx45.6) is 
phosphorylated in vivo by PKA at S395, resulting in increased gap junction coupling 
and hemichannel opening, which sustain metabolic coupling and transport in lens 
fibers (Liu et al., 2011). Cx50 phosphorylation at S395 seemed not responsible for 
alterations in channel conductance (Liu, et al., 2011). Phosphorylation of Cx50 at S364 
(Yin et al., 2000) appears to stimulate Cx50 turnover primarily through proteasome 
pathway and this phosphorylation inhibits the cleavage of Cx50 by caspase-3 (Yin et 
al., 2008).  
 
Cx56 is phosphorylated at S493 and S118 in response to PKC activation using TPA 
(12-0-tetradecanoyl phorbol 13-acetate). It is suggested that phosphorylation of Cx56 
at S118 is involved in the TPA-induced decrease in intercellular communication and 
acceleration of Cx56 degradation (Berthoud, et al., 1997). 
 
3.1.3 Phosphorylation of Panxs 
 
Currently, there is limited information about Panx phosphorylation events, it has been 
speculated that, in analogy to Cx-phosphorylation, the gating of Panx-based channels 
would be affected by phosphorylation. Consensus phosphorylation-sites have been 
suggested based on prediction for Panx1 and Panx3 (Barbe et al., 2006; Penuela et al., 
2007) (Fig. 1, Table 1 and Fig. 2A). Very recently, Panx2 seemed to be phosphorylated 
at S514 (Ultanir et al., 2012), this is the only phosphorylation site that is biochemically 
confirmed for Panxs. 
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3.2 Glycosylation 
 
3.2.1 Glycosylation of Cxs 
 
Cxs proteins seem not to be glycosylated and probably lack potential glycosylation 
sites in their extracellular loops. The amino termini of several Cxs contain potential 
consensus N-glycosylation sites. Due to their localization in the cytoplasm and their 
accesibility to the glycosylating enzymes, they are not utilized (Rahman et al., 1993; 
Saez, et al., 2003; Wang et al., 1995). However, the activity of Cx43 channels can be 
altered by preventing protein glycosylation with tunicamycin or by removal of 
extracellular-located glycans by enzymatic deglycosylation (Wang and Mehta, 1995; 
Wang, et al., 1995). Also, the formation of Cx43 gap junctions is hampered by 
oligosaccharide moieties of the glycoproteins of the plasma membranes, while 
inhibition of glycosylation abrogates these constraints (Wang and Mehta, 1995). 
Glycosylation of N-cadherin mediated by cell surface sialic acid is also associated with 
inhibition of Cx43 traffic to the plaque and reduced Cx43 gap junction functions in 
cancer cells (Li et al., 2010).  
 
3.2.2 Glycosylation of Panxs 
 
In contrast to Cx channels, the formation of functional Panx channels at the plasma 
membrane and the distribution of Panxs are both regulated by glycosylation and by 
the interaction between Panx family members (Penuela et al., 2009). Glycosylation 
also plays an important role in trafficking of Panxs to the cell surface.  
Panx1 and Panx3 (Boassa et al., 2007; Boassa et al., 2008; Penuela, et al., 2007) and 
Panx2 (Penuela, et al., 2009) are glycoproteins, consisting of probably only one glycan 
chain (Penuela, et al., 2009). The consensus site for N-linked glycosylation of Panx1 is 
in the second extracellular loop on N254 (Penuela, et al., 2007), Panx3 can be 
glycosylated on N71 (Penuela, et al., 2007) and Panx 2 glycosylation occurs on N86 
(Penuela, et al., 2009), both in their first extracellular loop (Fig. 1 and Fig. 2A). Panx1 
is shown to exist in three different glycosylation states: a core unglycosylated protein 
(Gly0), a high mannose-glycosylated protein (Gly1) associated within the ER and a 
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complex, extensively glycosylated species (Gly2) that is modified in the Golgi 
apparatus prior to cell surface delivery, Panx2 is shown to exist only as Gly0 species 
and Gly1 species and Panx3 exists as Gly1 species and Gly2 species (Boassa, et al., 
2007; Boassa, et al., 2008; Penuela, et al., 2007; Penuela, et al., 2009; Prochnow et al., 
2009) (Fig. 2B). In vivo, not all Panx isoforms are due to glycosylation. Distinct 
regulatory mechanisms control Panx1 and Panx3 in the testis, efferent ducts, and in 
the different regions of the epididymis. Changes in glycosylated Panx isoforms may be 
regulated by androgens, which may underlie the increased number of isoforms 
observed following orchidectomy (Turmel et al., 2011). In support of this, N-
glycosylation has already been demonstrated to be androgen-dependent in the rat 
epididymis (Iusem et al., 1984). 
 
Glycosylation was proposed to control Panx1 trafficking to the cell surface (Boassa, et 
al., 2007). The glycosylation-deficient mutant Panx1N254Q (Boassa, et al., 2007), 
showed trafficking defects and exhibits a more prominent intracellular distribution 
(Penuela et al., 2008). Upon coexpression with Panx1, the delivery of Panx1N254Q, is 
rescued to the cell surface (Boassa, et al., 2008). Consistent with this, the trafficking 
mutant Panx3-GFP is mainly found at the cell surface upon cotransfection with Panx1, 
and co-expressing Panx1N254Q with Panx3-GFP colocalizes only at intracellular sites 
(Penuela, et al., 2009). These data suggest that glycosylation-deficient mutant 
Panx1N254Q hinders the trafficking of Panx3-GFP towards the cell surface. The 
glycosylation-deficient mutants Panx1N254Q and Panx3N71Q were shown to be capable 
of forming functional channels suitable for dye uptake (Penuela, et al., 2007), 
indicating that a subpopulation of these mutants can traffic to the plasma membrane. 
In contrast, zfPanx1N246K, which is a glycosylation-deficient mutant of zebrafish Panx1, 
is able to traffic to the cell surface, but showed impaired uptake of ethidium bromide 
compared with wild type zfPanx1 (Prochnow, et al., 2009). Moreover, Gehi and 
coworkers provided evidence that Panx1 needs to be glycosylated to the Gly2 species 
to be properly trafficked to the cell surface, and that the C-terminal domain of Panx1 
is crucial for Panx1 delivery and retention at the cell surface (Gehi et al., 2011). In the 
absence of the C-terminal domain, glycosylation of Panx1 is limited to Gly1 and 
maturation of Panx1 into Gly2 species is inhibited, resulting in retention of Panx1 in 
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the ER (Gehi, et al., 2011). The c-terminaly truncated Panx1T307 is glycosylated 
primarily to Gly1 species and resides in the intracellular compartments. Intermixing 
with Panx1 does not result in the rescue of Panx1T307 to the cell surface, moreover 
Panx1T307 is acting dominantely to reduce the delivery of Panx1 to the cell surface 
(Gehi, et al., 2011).  
Whereas Panx1, even the Gly0 species (Boassa, et al., 2008), and Panx3 are able to 
traffic to the cell surface to form functional hemichannels, Panx2 mainly resides in the 
intracellular compartments (Penuela, et al., 2009). Its tempting to assume that the 
large C-terminal domain of Panx2 hinders its trafficking. Although a subpopulation of 
Panx2 was detected at the plasmamembrane (Penuela, et al., 2009; Zappala et al., 
2006), forming functional Panx2 hemichannels suitable for dye uptake, albeit less well 
than Panx1 or Panx3 (Penuela, et al., 2009). Interestingly, coexpression of Panx2 with 
Panx1, reduces this dye uptake compared with Panx1 or Panx2 alone (Penuela, et al., 
2009) (reviewed in {D'hondt, 2010 #346}). The level of PTMs of Panx2 seems to be 
less compared to Panx1 and Panx3 (Penuela, et al., 2009), probably because Panx2 
does not exist in Gly2 species.  
 
Besides the crucial role of glycosylation for proper Panx delivery to the cell surface, 
the transport of Panx1 and Panx3 from the ER to the Golgi apparatus is mediated 
through COPII vesicles (Bhalla-Gehi et al., 2010). This resembles the delivery process 
of Cx43 to the cell surface (Thomas et al., 2005). In the Golgi apparatus Panxs are 
substrates for further glycosylation to Gly2 species, editing and transport to the cell 
surface.  
 
In conclusion, a population of all three Panx family members can reside and function 
at the cell surface as single-membrane channels. The interaction of the different Panx 
subtypes seem to be highly regulated by the state of glycosylation and their 
intermixing can significantly affect the functionality of the formed monomeric or 
heteromeric channels. 
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3.3 Proteolysis 
 
3.3.1 Proteolysis of Cxs 
 
Proteolysis has been associated with Cx43, Cx46 (Cx44 and Cx56, bovine and chicken 
orthologue respectively), Cx50 (Cx49 and Cx45.6 bovine and chicken orthologue 
respectively) and Panx1 (Fig. 1). Endogenous C-terminal tail truncation has been 
described of Cx43, Cx50, and the presence of a free C-terminal fragment of Cx43 is 
observed in cultured cells (Joshi-Mukherjee et al., 2007) (Fig. 1). Gap junction channel 
properties and hence gap junctional intercellular communication are altered by C-
terminal domain-truncation of Cx43 (Bates, et al., 2007). Yet, no evidence was found 
for alterations in motility as a result of this truncation (Bates, et al., 2007; Moorby, 
2000). 
 
Autophagy was shown to be involved in proteolysis of the wild-type Cx50 and Cx43 
(Lichtenstein et al., 2011). Colocalization of intracellular Cxs with p62, a protein that 
might serve as a cargo receptor for autophagic degradation, was detected. Moreover, 
treatment with chloroquine, a lysosomal protease inhibitor, blocked the starvation-
induced decrease in Cx levels (Lichtenstein et al., 2011). This is fully supported by a 
recent report showing that gap junctions, following internalization, are degraded by 
autophagy (Fong et al., 2012). Autophagy is also shown to modulate the 
internalization and degradation of Cx43 by ubiquitinylation of plasma membrane Cxs 
(Bejarano et al., 2012). 
 
Cx46 and Cx50, which are expressed in human lens fiber cells in the lens core 
(Donaldson et al., 1992; Paul et al., 1991; White et al., 1992) undergo proteolytic 
cleavage of their C termini during fiber maturation. Cx46 and Cx50 are important for 
lens growth and transparency (Gong et al., 2007). Absence of Cx46 and Cx50, resulting 
in aberrant gap junction communication, resulted in different types of cataracts by 
affecting lens inner fiber cells (Xia et al., 2006). Nuclear cataracts caused by disruption 
of Cx46 in mice were associated with the proteolysis of gamma-crystallins (Gong et al., 
1997)(Xia, et al., 2006), leading to its aggregation and subsequent opacification of the 
lens (Baruch et al., 2001). The Ca2+-dependent cysteine protease (calpain) Lp82 is 
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shown to be a key initiator of gamma-crystallin proteolysis (Baruch, et al., 2001), 
implying a crucial role for Cx46 gap junctions in maintaining Ca2+ homeostasis and 
hence controlling calpain Lp82 (Baruch, et al., 2001). Also age-related cataracts in 
Cx46-knock-out mice are the result of increased intracellular [Ca2+], thereby activating 
the calpain3 isoform Lp82/85 (Tang et al., 2007). Cleavage of Cx46 is also associated 
with a spatial redistribution of gap junction plaques in the lens (Jacobs et al., 2004). 
Cx44, the bovine orthologue for Cx46 is cleaved at L255 (Shearer, et al., 2008). 
Advances in basic research and discoveries of clinical disorders of Cx46 and Cx50 
dysfunctions that are associated with cataractogenesis and lens development are 
reviewed in (Jiang, 2010). 
Two calpain-cleavage sites (E290 and S300) were identified in Cx50 (Lin et al., 1997). 
Also Cx49, the bovine orthologue for Cx50 (Rao et al., 1990), is cleaved by calpain at 
E290 (Lin, et al., 1997; Shearer, et al., 2008) and S300 (Lin, et al., 1997). C-terminal 
truncation of Cx50 did not inhibit the formation of homotypic or heterotypic channels. 
However, a significant decrease in conductance was observed for truncated channels, 
a phenomenon independent of alterations in voltage-gating sensitivity, kinetics, or 
chemical gating (DeRosa et al., 2006). Cx45.6, the chicken orthologue of Cx50, is a 
direct target of caspase-3 and the cleavage by caspase-3 between G361 and E367 
leads to the development-associated truncation of Cx45.6, which can be modulated by 
the specific Cx phosphorylation (Yin et al., 2001; Yin, et al., 2000; Yin, et al., 2008). 
 
3.3.2 Proteolysis of Panxs 
 
Panx1 is a target of caspase 3 and 7-mediated proteolysis. Two caspase cleavage sites 
were identified, namely in the cytoplasmic loop domain at aa 164-167 (DMRD) and at 
the C-terminal domain at aa 376-379 (DVVD) (Fig. 1, Fig. 2A). Caspase-mediated 
cleavage of the C-terminal domain of Panx1 is necessary for the induction of Panx1-
mediated plasma membrane permeability during apoptosis. Expression of truncated 
Panx1 (at the putative caspase cleavage site) resulted in a constitutively open channel 
(Chekeni, et al., 2010). This is underpinned by a very recent study showing that 
caspase cleavage of Panx1 leads to activation of the channel by dissociation of the C-
terminal domain from the channel pore (Sandilos, et al., 2012). These results suggest 
that the intact, pore-associated C-terminal domain inhibits the full-length hPANX1 
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channel. Consequently caspase-mediated cleavageof Panxs removes the key inhibitory 
C-terminal domain determinants, thereby activating hPanx1 (Sandilos, et al., 2012). 
 
 
3.4 N-Acetylation  
 
3.4.1 Acetylation of Cxs 
 
Acetylation in Cxs may be involved in regulation of gating and permeability of Cxs, 
since the N termini of Cxs regulate channel gating and permeability (Oh et al., 2000; 
Oh et al., 1999; Purnick, Benjamin, et al., 2000; Purnick, Oh, et al., 2000; Verselis et al., 
1994). Moreover, the first 10 residues of Cx26 and Cx32 has been suggested to lie in 
the channel pore (Purnick, et al., 2000).  
In Cx44 and Cx49, the N-terminal M-residue is endogenously removed and the newly 
exposed N-terminal G-residue becomes acetylated (Shearer, et al., 2008). 
Multiple acetylations sites were identified in the cytoplasmic loop domain of Cx26, a 
region involved in gating by pH and intramolecular interactions in many Cxs (Fig 1) 
(Manthey et al., 2001; Ponsaerts et al., 2010; Shibayama et al., 2006). Acetylation was 
identified at M1 by MS/MS (tandem mass spectrometry) and at K15, K102, K103, 
K105, K108, K112 and K116 by MS (Locke, et al., 2009) (Fig. 1). 
N-terminal acetylation occurs in all proteins with the M1D2 sequence, such as Cx26, 
hereby eliminating its positive charge. This can have a profound impact on Cx-channel 
gating, since the N-terminal domain folds into the aqueous pore to act as a voltage 
sensor and gate in Cxs (Maeda, et al., 2009; Oh et al., 2004; Oshima et al., 2007; 
Purnick, et al., 2000).  
In Cx26, acetylation at K15 may affect charge selectivity to permeants and/or voltage 
gating, since K15 is located at the outer edge of the cytoplasmic entrance/vestibule of 
the channel pore near the ‘hinge’ region at which the N-terminal domain turns into 
the pore to form the voltage sensor/gate (Maeda, et al., 2009; Purnick, et al., 2000). 
Several internal K-residues are potentially acetylated in the Cx26 cytoplasmic loop 
domain near TM2. The Cx cytoplasmic loop domain is involved in gating by pH and 
related intramolecular interactions (Manthey, et al., 2001; Shibayama, et al., 2006), so 
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dynamic modulation of the charge of this domain by multiple acetylations could 
modulate these processes, as occurs in other proteins (Yang and Seto, 2008). 
 
A portion of bovine Cx44 and Cx49 is acetylated. N-acetylation of the newly exposed N 
termini was shown to occur upon removal of the N-terminal Met residue (Shearer, et 
al., 2008).  
N(epsilon)-lysine acetylation of Cx43 inhibits its association to gap junctions at 
intercalated discs and may have physiopathological consequences for cell to cell 
coupling and cardiac function (Colussi et al., 2011). 
Acetylation may also regulate Cx protein levels. Histone deacetylase inhibitors (like 
Trichostatin A (TSA)), which interfere with the acetylation of core histones, affect the 
chromatin structure and thus the gene expression (Papeleu et al., 2005; Vanhaecke et 
al., 2004). TSA differentially affected Cx protein levels and localization and to 
enhanced gap junctional intercellular communication in primary rat hepatocyte 
cultures. TSA treatment increased Cx32 protein levels and Cx43 accumulation in the 
nuclear compartment of primary cultured hepatocytes. TSA treatment resulted in a 
decrease of Cx26 protein levels and Cx26 was preferentially located in the cytosol of 
cultured cells (Vinken, et al., 2006).  
 
3.4.2 Acetylation of Panxs 
 
Panx1 acetylation sites were predicted at K202, K203 and K211 and Panx2 acetylation 
sites at K456 and K459 (Fig. 1, Fig. 2A). But no functional evidence is provided for 
acetylation of Panxs. 
 
3.5 S-Nitrosylation  
 
3.5.1 Nitrosylation of Cxs 
 
The NO donor S-nitroso-N-acetylpenicillamine significantly reduced dye transfer 
through Cx37 gap junction channels in cultured human umbilical vein endothelial cells 
(Kameritsch et al., 2005). According to this study, also electrical coupling of Cx37 gap 
junction channels was reduced upon application of NO in microvascular endothelial 
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cells (McKinnon et al., 2009). Recently, Straub and coworkers found that Cx43 is 
constitutively S-nitrosylated on C271 (Fig. 1), this modification might regulate gap 
junction channel permeability at the myoendothelial junctions, which are anatomic 
structures that facilitate direct smooth muscle cell and endothelial cell communication 
within the resistance artery, in the blood vessel wall (Straub et al., 2011).  
Also, Cx hemichannels seem to be regulated by S-nitrosylation. Metabolic inhibition 
increases the number of Cx43 hemichannels on the cell surface, and enhances dye 
uptake. This is associated with multiple molecular changes, including S-nitrosylation 
of intracellular Cx43 C-residues (Retamal et al., 2006; Retamal et al., 2007). In 
cardiomyocytes and cortical astrocytes, opening of Cx43 hemichannels induced by 
hypoxia, oxygen deprivation or during long periods of ischemia might be mediated by 
dephosphorylation of Cx43 hemichannels or by oxidative modification due to 
increased NO-production (and other reactive oxygen species) (Bao, et al., 2004; Kim et 
al., 1999). Also, regulation of Cx46 hemichannels by NO has been suggested (Retamal 
et al., 2009). 
 
3.5.2 Nitrosylation of Panxs 
 
Currently, evidence for a direct modulation of Panx1 channels by S-nitrosylation is 
lacking. Although, since Panx1 contains multiple cysteine residues and since Panx1 is 
expressed in tissues with enhanced NO production, it is not unlikely that Panx1 
channels undergo S- nitrosylation. Furthermore, mutation of C346 in the carboxyl 
terminus of Panx1 (Bunse et al., 2010) and of C40 in the pore-lining region of the first 
transmembrane domain of Panx1 results in a constitutively leaky channel (Bunse et 
al., 2011), indicating the importance of Panx1 cysteine residues in regulating channel 
gating and permeability (Fig. 1, Fig. 2A).  
Moreover, Panx1 and Panx2 channels have been implicated in ischemia-induced 
neuronal cell death, a condition in which NO production is markedly enhanced 
(Bargiotas et al., 2011). In line with this, Panx hemichannel opening may mediate 
excessive NO generation and neuronal cell death during ischemia. This was attenuated 
by NO synthase inhibitor or reduction of oxidized sulfhydryl groups with the reducing 
agent DTT (Zhang et al., 2008). Further studies are required to unravel the effect of S-
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nitrosylation on Panx channel gating and permeability. 
 
 
3.6 Ubiquitination and sumoylation  
3.6.1 Ubiquitination of Cxs 
 
Ubiquitination of Cxs with the focus on intracellular trafficking and degradation of Cx-
proteins has been reviewed in (Leithe and Rivedal, 2007) (Fig. 1). 
Cx43 is monoubiquitinated at K9 and K303 (Wagner et al., 2011). PKC- and MAPK-
mediated ubiquitination of Cx43 at the plasma membrane probably regulates Cx43 
endocytosis. Moreover, Nedd4-mediated ubiquitination of Cx43 in the plasma 
membrane, which is modulated by Cx43 phosphorylation (Leithe and Rivedal, 2007), 
seems required to initiate autophagy-dependent internalization and degradation of 
Cx43 (Bejarano, et al., 2012). In line with this study, also the ubiquitin-binding protein 
p62/sequestosome 1 was identified in targeting internalized Cx43 gap junctions to 
autophagic degradation (Fong, et al., 2012). 
Ubiquitination of Cx43 does neither control gap junction stability nor Cx43 turnover, 
since a mutant Cx43 with all lysines converted to arginines behaved similarly to wild 
type Cx43 in the presence of proteasomal and lysosomal inhibitors (Dunn, et al., 
2011). 
Cx46-induced Cx43 degradation is likely mediated by the ubiquitin-proteasome 
pathway, involving the intracellular domain of the C-terminal tail of Cx46 (Banerjee et 
al., 2011).  
Very recently, Kjenseth and coworkers were the first to identify Cx43 as a 
SUMOylation target protein at K144 or K237, thus Cx43 gap junctions may be 
regulated by the SUMO system (Kjenseth et al., 2012) (Fig. 1). 
 
3.6.2 Ubiquitination of Panxs 
 
Panx1 is shown to be ubiquitinated at K381 and K409 (Kim et al., 2011) (Fig. 1, Fig. 
2A), but functional evidence remain elusive. 
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3.7 Lipidation  
 
3.7.1 Lipidation of Cxs 
 
Although it is well established that Cxs are associated with lipid rafts (Locke et al., 
2005), only a few reports of lipidation in Cxs exist. Palmitoylation of the end of the C-
terminal domain of mCx32 (residues 277–283) (Locke et al., 2006) and palmitoylation 
of one or both cysteines in the carboxyl-terminal CSAC sequence of the C-terminal 
domain of Cx32 (Linder and Deschenes, 2003) is described and the "unspecified 
prenylation" of Cx32 C280SAC283 in transfected COS cells (Huang et al., 2005) was 
shown to be geranylation (Locke, et al., 2006) (Fig. 1).  
 
3.7.2 Lipidation of Panxs 
 
Panx2 has a depalmitoylated (~60 kDa) form, which resides primarily at the plasma 
membrane, while the palmitoylated form of Panx2 (~85 kDa) was suggested to reside 
in the Golgi and/or ER (Swayne et al., 2010). The exact site where the palmitoylation 
occurs is not known yet. 
 
 
3.8 Hydroxylation  
Hydroxylation occurs in the N-terminus of Cx32 at either N2 or N14 (Locke, et al., 
2006) and in Cx26 at N14 in the N-terminal domain, at N113 in the cytoplasmic loop, 
and at either N170 or N176 in the second extracellular loop (Locke, et al., 2009; Locke, 
et al., 2006) (Fig. 1). 
N14Y and N14K are two Cx26deaf mutations at N14 that affect gating, the N14Y 
mutation leads to reduced junctional conductance, and N14K mutation generates 
functional channels, but they lack voltage-dependence (Arita et al., 2006; Maeda, et al., 
2009; Purnick, et al., 2000). Because N14K does not introduce a charge, this mutation 
may be a better mimick for the lack of hydroxylation. N176 might be directly involved 
in the docking interaction between apposed hemichannels (Maeda, et al., 2009).  
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3.9 Methylation 
 
In Cx26, K61, R75 and either K221 or K223 were defined as methylation sites (Locke, 
et al., 2009) (Fig. 1). Importantly, R75 in Cx26 is affected by disease-causing 
mutations in Cx26. For instance, R75Q or R75W mutations in Cx26 fail to form 
functional junctional channels, display altered voltage-dependence and permeability 
and act as dominant negative with other Cxs including Cx26. A role of uncoupled 
R75W channels in the death of cochlear cells and in dominant deafness is possible and 
this has been associated with Palmoplantar keratoderma (Chen et al., 2005; Deng et 
al., 2006; Richard et al., 1998).  
 
 
3.10 Deamidation  
 
In the C-terminal domain of Cx43, deamidation occurs at N329 and Q333(Huang, et al., 
2011) (Fig. 1). In bovine Cx49, deamidation occurs on N121 (Shearer, et al., 2008). 
Biochemical evidence still needs to be provided. 
 
 
 
Conclusion 
 
Although important insights have been gained regarding PTMs as a regulatory 
mechanism for Cx and Panx communicating channels at the cellular level and PTM-
target sites have been associated with disease-causing mutations, still in vivo proof for 
the relevance of PTM-dependent Cx- and Panx-channel regulation is often lacking. 
Thus, mutations in Cx and Panx-coding genes may lead to the defective Cx and Panx 
channels, in part because they lack PTMs essential for their function as 
communicating channels in controlling physiological processes. Recently this has 
been shown in a Cx43-phosphorylation dead- and Cx43-phosphorylation mimick-
knock-in mouse model (Remo, et al., 2011). Given the central role of PTMs in 
controlling many cell biological aspects of and functional properties of Cx and Panx 
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channels, unequivocally establishing their relevance in vivo and in pathological 
conditions will be important. PTM directly affect the activity, trafficking, localization 
and expression of gap junction channels. Furthermore, given the fact that both Cxs and 
Panxs can form gap junction channels and hemichannels (Ishikawa et al., 2011; Kar et 
al., 2012; Wang et al., 2012) and the emerging roles for Cx hemichannels in 
physiological processes (Kar, et al., 2012; Stehberg et al., 2012), it will be important to 
elucidate how PTMs influence both channel types. PTMs does not necessarily need to 
exert the same outcome on gap junctions versus hemichannels, as molecular events 
like intramolecular loop/tail interactions underlying their opening and closing may 
have opposite outcomes (Evans et al., 2012; Ponsaerts, et al., 2010; Ponsaerts et al., 
2012). Finally, beyond phosphorylation events, it is critical to understand how other 
chemical modifications of Cx and Panx proteins (like S-nitrosylation, acetylation and 
deamidation) regulate their activity and how these are altered during pathological 
conditions. 
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Tables and Figures: 
 
Table 1 Phosphorylation of connexins and pannexins 
Known phosphorylation sites for different connexin and pannexin subtypes, their 
modifying enzymes and the functional concequences of the phosphorylation. 
AA = number of amino acids 
MW = Molecular weight 
BIP = Basal Isoelectric point 
NT = cytoplasmic N-terminal domain 
TM = transmembrane domain (TM; TM1, TM2, TM3, TM4) 
EL = extracellular loop domain (EL1 and EL2) 
CL = cytoplasmic loop domain  
CT = cytoplasmic C-terminal domain 
P-site = phosphorylation site 
1 (Locke, et al., 2006), 2 (Locke, et al., 2009), 3 (Park, et al., 2000), 4 (de Zwart-Storm, 
et al., 2008), 5 (Diestel, et al., 2004), 6 (Saez, et al., 1990), 7 (Chanson, et al., 1996), 8 
(Stauch, et al., 2012), 9 (Diez, et al., 1995), 10 (Alev, et al., 2008), 11 (Urschel, et al., 
2006), 12 (Patel, et al., 2006), 13 (Kothmann, et al., 2009), 14 (Saito et al., 2000), 15 
(Morel, et al., 2010), 16 (Kemp and Pearson, 1990), 17 (Kennelly and Krebs, 1991), 18 
(van Rijen, et al., 2000), 19 (Huang, et al., 2011), 20 (Swenson, et al., 1990), 21 (Lin, et 
al., 2001), 22 (Solan and Lampe, 2008), 23 (Cottrell, et al., 2003), 24 (Zhou, et al., 
1999), 25 (Warn-Cramer, et al., 1998), 26 (Warn-Cramer et al., 1996), 27 (Norris, et 
al., 2008), 28 (Lampe and Lau, 2000), 29 (Lampe, et al., 1998), 30 (Kanemitsu, et al., 
1998), 31 (Arnold et al., 2005), 32 (Sato et al., 2008), 33 (Laird, 2005), 34 (Xie et al., 
1997), 35 (Axelsen et al., 2006), 36 (Bao, et al., 2004), 37 (Doble, et al., 2000), 38 (Ek-
Vitorin, et al., 2006), 39 (Dang et al., 2006), 40 (Solan and Lampe, 2007), 41 (Doble, et 
al., 2004),42 (Srisakuldee, et al., 2009), 43 (Miura, et al., 2007), 44 (Dang, et al., 2003), 
45 (Giepmans et al., 2001), 46 (Toyofuku, et al., 2001), 47 (Bellei et al., 2008), 48 
(Malone et al., 2007), 49 (Procida et al., 2009), 50 (Guo et al., 2008), 51 (Huang et al., 
2007), 52 (Brill et al., 2009), 53 (Munton et al., 2007), 54 (Remo, et al., 2011), 55 
(Cooper and Lampe, 2002), 56 (Lampe, et al., 2006), 57 (Paulson et al., 2000), 58 
(Shah et al., 2002), 59 (Britz-Cunningham et al., 1995), 60 (TenBroek, et al., 2001), 61 
(Yogo et al., 2002), 62 (Beardslee, et al., 2000), 63 (Faigle et al., 2008), 64 (Lurtz and 
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Louis, 2007), 65 (Richards, et al., 2004), 66 (Palatinus, et al., 2011a), 67 (Straub, et al., 
2009), 68 (Solan et al., 2003), 69 (Saez et al., 1997), 70 (Park et al., 2007), 71 (van 
Veen, et al., 2000), 72 (Hertlein, et al., 1998), 73 (Saleh, et al., 2001), 74 (Lin, et al., 
2004), 75 (Zampighi, et al., 2005), 76 (Shearer, et al., 2008), 77 (Liu, et al., 2011), 78 
(Yin, et al., 2001), 79 (Yin, et al., 2008), 80 (Berthoud, et al., 1997), 81 (Ultanir, et al., 
2012),  
 
 
 
 
Figure 1  
Schematic representation of the sites for post-translational modifications of 
communicating junction proteins. The post-translational modification sites are 
predicted sites that were identified using phosphoproteomic strategies. 
Each modification is represented by another color. “B” means bovine orthologue; “C” 
means chicken orthologue. 
Black = Phosphorylation sites 
Orange= Glycosylation sites 
Pink = Proteolysis sites 
Dark blue = Lipidation sites 
Purple = S-nitrosylation sites 
Red = Acetylation sites 
Grey = Deamidation sites 
Turquoise blue = Hydroxylation site 
Green = Ubiquitination site 
Brown = Methylation sites 
 
NT = cytoplasmic N-terminal domain 
TM = transmembrane domain (TM; TM1, TM2, TM3, TM4) 
EL = extracellular loop domain (EL1 and EL2) 
CL = cytoplasmic loop domain  
CT = cytoplasmic C-terminal domain 
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(see text and table 1 for references) 
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Figure 2 
A. Schematic representation of the transmembrane topology of the three pannexin 
family members. Based on sequence analysis, Panxs are predicted to contain 
predicted N-glycosylation (orange residues) (Penuela, et al., 2007), phosphorylation 
(black) sites (Penuela, et al., 2007), proteolysis (pink) sites (Chekeni, et al., 2010), 
acetylation (red) sites, S-nitrosylation (purple) sites (Bunse, et al., 2010) and 
ubiquitination (green) sites (Kim, et al., 2011) (* = site is biochemically confirmed). 
Panx1 (426 amino acids (aa)), Panx2 (667 aa) and Panx3 (392 aa) are integral 
membrane proteins consisting of 4 transmembrane (TM) domains (numbers indicate 
the aa position of TM domains), 2 extracellular loops and 1 intracellular loop. Panx1 
has a N-glycosylation site at N254, Panx2 has a predicted N-glycosylation site at N86, 
and Panx3 at N71. (Modified from (Penuela, et al., 2009), 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=C
itation&list_uids=19692571) 
B. Panx1 and Panx3 are glycosylated to both a high-mannose form (Gly1) and a 
complex, extensively glycosylated form (Gly2), while Panx2 has only been reported as 
a high-mannose form (Gly1) or a core unglycosylated isoform (Gly0).  
C. Formation of pannexin channels. Homomeric Panx1 (Bruzzone et al., 2005; 
Dvoriantchikova et al., 2006) and Panx3 (Penuela, et al., 2007) but not Panx2 
(Bruzzone et al., 2003) hemichannels are formed. Heteromeric Panx1/Panx2 
(Penuela, et al., 2009) and Panx1/Panx3 (Penuela, et al., 2009) hemichannels can be 
formed, no reports on Panx2/Panx3 hemichannels. Formation of pannexin gap 
junction channels is still debated ($) (reviewed in (D'hondt, et al., 2009), (Sosinsky, et 
al., 2011)). Yet, homotypic Panx1 (Bruzzone, et al., 2003), homotypic Panx3 [249] and 
heterotypic Panx1/Panx2 (Bruzzone, et al., 2005; Bruzzone, et al., 2003; 
Dvoriantchikova, et al., 2006) gap junction channels have been described. 
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